IL6R blockade may have a more beneficial effect for T2D with lower hba1c levels in AFR vs EUR, as well as potential beneficial effects for glaucoma, keratoconjunctivitis, and periodontitis. The gene discussed is IL6R; the disease is type 2 diabetes mellitus.